LEGAL DISCLAIMERS - THIS IS A PAID ADVERTISEMENT.
This is a paid advertisement, not a recommendation nor an offer to buy or sell securities.
Our business model is to be financially compensated to market and promote public companies. By
reading this email, our website / media webpage you agree to the terms of our disclaimer, which are
subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to
provide investing advice or anything of an advisory or consultancy nature and are therefore
unqualified to give investment recommendations. Always do your own research and consult with a
licensed investment professional before investing.
This communication is never to be used as the basis for making investment decisions and is
for entertainment purposes only. At most, this communication should serve only as a starting point
to do your own research and consult with a licensed professional regarding the companies profiled
and discussed. Conduct your own research. Companies with low price per share are speculative and
carry a high degree of risk, so only invest what you can afford to lose. By using our service you
agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or
otherwise, that may occur due to any action you may take based on the information contained within
our website / media webpage.
As a result of this communication we will be dropping you in a variety of places featuring
Cardiol Therapeutics; including but not limited to, directly on the Press Release that is hosted on
the profiled Company’s site here; and the
featured interview on FinTech.TV here.
COMPENSATION DISCLOSURE.
IRP Holdings, dba IRPub, has received Seventy-Five Thousand Dollars paid by a third party,
Anchor IR LLC, for and on behalf of Cardiol Therapeutics (NASDAQ: CRDL; TSX: CRDL) for brand
awareness, marketing distribution and investor education marketing for a period of 30 Days. IRPub
has not received any shares nor owns any shares of Cardiol Therapeutics (NASDAQ: CRDL; TSX: CRDL),
however, Anchor IR has received a contract from the company containing an offer to purchase Stock
Options at a strike price of $2.56 CAD. The total amount of options that may be exercised/purchased
is up to 150,000 Shares. This Stock Option Agreement is NOT an
award of shares to Anchor IR, it is an opportunity for Anchor IR to take a position in the company
pursuant to the Agreement. Should Anchor IR decide to execute their Options, this information will
be updated and disclosed immediately reflecting the amount of options executed and the date of
execution.
DISCLOSURE OF HOLDINGS
WhatsOnFinance, IRP Holdings Corporation dba IRPub, DO NOT hold any position in the stock(s)
and/or financial instrument(s) mentioned in the above piece. We have been paid to produce this piece
by the Company or companies mentioned above. However, Anchor IR, a partner company to IRP Holdings,
has received a contract from the company containing an offer to purchase Stock Options at a strike
price of $2.56 CAD. The total amount of options that may be exercised/purchased is up to 150,000
Shares. This Stock Option Agreement is NOT an award of shares to
AnchorIR LLC, it is an opportunity for Anchor IR to take a position in the company pursuant to the
Agreement. Should Anchor IR decide to execute their Options, this information will be updated and
disclosed immediately reflecting the amount of options executed and the date of execution.
THIS IS A PAID ADVERTISEMENT.
This communication is a paid advertisement and is not a recommendation to buy or sell
securities. IRPub, and its owners, managers, employees, and assigns (collectively “the Company”) has
been paid by the profiled company or a third party to disseminate this communication. In this case
the Company has been paid by a third party, Anchor IR LLC, for and on behalf of Cardiol Therapeutics
(NASDAQ: CRDL; TSX: CRDL), Seventy-Five Thousand Dollars US dollars for marketing services for a period of 45
days. To conduct investor relations advertising, marketing and publicly disseminate information not
limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker
Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads,
Responsive Ads. This compensation is a major conflict with our ability to be unbiased, more
specifically: This communication is for entertainment purposes only. Never invest purely based on
our communication.
Gains mentioned in this article, in our newsletter and on our website may be based on
end-of-day or intraday data. We have been compensated by a third party, AnchorIR LLC, for and on
behalf of Cardiol Therapeutics (NASDAQ: CRDL; TSX: CRDL) to conduct investor awareness advertising
and marketing. Therefore, this communication should be viewed as a commercial advertisement only.
The information is collected from public sources, such as the profiled company’s website and press
releases, but is not researched or verified in any way whatsoever to ensure the publicly available
information is correct. Furthermore, IRP & Anchor IR often employ independent contractor writers who
may make errors when researching information and preparing these communications regarding profiled
companies. Independent writers’ works are double-checked and verified before publication, and
approved by the company that is featured herein, but it is certainly possible for errors or
omissions to take place during editing of independent contractor writer’s communications regarding
the profiled company(s).
This email and possible webpage(s), are owned, operated and edited by IRP Holdings
Corporation. Any wording found on this email, or our website / media webpages or disclaimer
referencing to “I” or “we” or “our” or “IRP” or “IRPub” refers to IRP Holdings Corporation. This
website / media webpages is a paid advertisement, not a recommendation nor an offer to buy or sell
securities. Our business model is to be financially compensated to market and promote small public
companies. By reading our website / media webpage you agree to the terms of our disclaimer, which
are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever
to provide investing advice or anything of an advisory or consultancy nature and are therefore are
unqualified to give investment recommendations. Always do your own research and consult with a
licensed investment professional before investing. This communication is never to be used as the
basis for making investment decisions and is for entertainment purposes only. At most, this
communication should serve only as a starting point to do your own research and consult with a
licensed professional regarding the companies profiled and discussed. Conduct your own research.
Companies with low price per share are speculative and carry a high degree of risk, so only invest
what you can afford to lose. By using our service you agree not to hold our site, its editor’s,
owners, or staff liable for any damages, financial or otherwise, that may occur due to any action
you may take based on the information contained within our website / media webpage.We do not advise
any reader take any specific action. Losses can be larger than expected if the company experiences
any problems with liquidity or wide spreads. Our website / media webpages are for entertainment
purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media
webpages may be based on end-of-day or intraday data. This publication and their owners and
affiliates may hold positions in the securities mentioned in our alerts, which we/they may sell at
any time without notice to our subscribers, which may have a negative impact on share prices. If we
own any shares we will list the information relevant to the stock and number of shares here: as
mentioned above IRP Holdings does not own shares in the profiled company, However, Anchor IR, a
partner company to IRP Holdings, has received a contract from the company containing an offer to
purchase Stock Options at a strike price of $2.56 CAD. The total amount of options that may be
exercised/purchased is up to 150,000 Shares. This Stock Option
Agreement is NOT an award of shares to Anchor IR, it is an opportunity for Anchor IR to take a
position in the company pursuant to the Agreement. Should Anchor IR decide to execute their Options,
this information will be updated and disclosed immediately reflecting the amount of options executed
and the date of execution.
Again, IRP Holdings Corporation and AnchorIR LLC’s business models are to receive financial
compensation to promote public companies. To conduct investor relations advertising, marketing and
publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications,
Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts,
Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of
interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as
a commercial advertisement only. We have not investigated the background of the hiring third party
or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares
of the profiled company at or near the time you receive this communication, which has the potential
to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our
database for the benefit of our future financially compensated investor relations efforts.
Frequently companies profiled in our alerts may experience a large increase in volume and share
price during the course of investor relations marketing, which may end as soon as the investor
relations marketing ceases. Our emails may contain forward-looking statements, which are not
guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy,
or completeness of the information on our website / media webpage. The information in our website /
media webpage is believed to be accurate and correct, but has not been independently verified and is
not guaranteed to be correct. The information is collected from public sources, such as the profiled
company’s website and press releases, but is not researched or verified in any way whatsoever to
ensure the publicly available information is correct. Furthermore, IRP Holdings and Anchor IR LLC
often employs independent contractor writers who may make errors when researching information and
preparing these communications regarding profiled companies. Independent writers’ works are
double-checked and verified before publication, but it is certainly possible for errors or omissions
to take place during editing of independent contractor writer’s communications regarding the
profiled company(s). You should assume all information in all of our communications is incorrect
until you personally verify the information, and again are encouraged to never invest based on the
information contained in our written communications. The information in our disclaimers is subject
to change at any time without notice.
We have not thoroughly investigated the background of Cardiol Therapeutics (NASDAQ: CRDL;
TSX: CRDL). The third party, profiled company, or their affiliates may liquidate shares of the
profiled company at or near the time you receive this communication, which has the potential to hurt
share prices. Frequently companies profiled in our alerts experience a large increase in volume and
share price during the course of investor awareness marketing, which often end as soon as the
investor awareness marketing ceases. We do not guarantee the timeliness, accuracy, or completeness
of the information on our site or in our newsletters. The information in our communications and on
our website is believed to be accurate and correct, but has not been independently verified and is
not guaranteed to be correct. The information is collected from public sources, such as the profiled
company’s website and press releases, but is not researched or verified in any way whatsoever to
ensure the publicly available information is correct. ALWAYS DO YOUR OWN RESEARCH and consult with a
licensed investment professional before making an investment. This communication should not be used
as a basis for making any investment
RISK OF INVESTING.
Investing is inherently risky. While a potential for rewards exists,
by investing, you are putting yourself at risk. You must be aware of the risks and be willing to
accept them in order to invest in any type of security. Don't trade with money you can't afford to
lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being
made that any account will or is likely to achieve profits or losses similar to those discussed on
this web site. We do not advise any reader take any specific action. Losses can be larger than
expected if the company experiences any problems with liquidity or wide spreads. Our website / media
webpage are for entertainment purposes only. Never invest purely based on our featured profiles on
Companies. Gains mentioned in our website / media webpage may be based on end-of-day or intraday
data. This publication and their owners and affiliates may hold positions in the securities
mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may
have a negative impact on share prices. The past performance of any trading system or methodology is
not necessarily indicative of future results All trades, patterns, charts, systems, etc., discussed
in this message and the product materials are for illustrative purposes only and not to be construed
as specific advisory recommendations. All ideas and material presented are entirely those of the
author and do not necessarily reflect those of the publisher.
CHANGES IN SHARE TRADING AND PRICE
Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate
shares of the profiled companies at any time, including at or near the time you receive this
communication, which has the potential to adversely affect share prices. Frequently companies
profiled in our articles experience a large increase in share trading volume and share price during
the course of investor awareness marketing, which often ends as soon as the investor awareness
marketing ceases. The investor awareness marketing may be as brief as one day, after which a large
decrease in share trading volume and share price may likely occur.
NO OFFER TO SELL OR BUY SECURITIES
This communication is not, and should not be construed to be, an offer to sell or a solicitation of
an offer to buy any security.
INFORMATION
Neither this communication nor the Publisher purport to provide a complete analysis of any company
or its financial position. This communication is based on information generally available to the
public and on an interview conducted with the company's CEO, and does not contain any material,
non-public information. The information on which it is based is believed to be reliable.
Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information.
Further, the information in this communication is not updated after publication and may become
inaccurate or outdated. No reliance should be placed on the price or statistics information and no
responsibility or liability is accepted for any error or inaccuracy. Any statements made should not
be taken as an endorsement of analyst views. You can email contact to [email protected].
NO FINANCIAL ADVICE
The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser
or a financial adviser. The Publisher has no access to non-public information about publicly traded
companies. The information provided is general and impersonal, and is not tailored to any particular
individual's financial situation or investment objective(s) and this communication is not, and
should not be construed to be, personalized investment advice directed to or appropriate for any
particular investor or a personal recommendation to deal or invest in any particular company or
product. Any investment should be made only after consulting a professional investment advisor and
only after reviewing the financial statements and other pertinent corporate information about the
company. Further, readers are advised to read and carefully consider the Risk Factors identified and
discussed in the advertised company's SEC, SEDAR and/or other government filings. Investing in
securities, particularly microcap securities, is speculative and carries a high degree of risk. Past
performance does not guarantee future results.
FORWARD LOOKING STATEMENTS
This communication contains forward-looking statements, including statements regarding expected
continual growth of the featured companies and/or industry. Statements in this communication that
look forward in time, which include everything other than historical information, are based on
assumptions and estimates by our content providers and involve risks and uncertainties that may
affect the profiled company's actual results of operations. These statements involve known and
unknown risks, uncertainties and other important factors that could cause the actual results and
performance to differ materially from any future results or performance expressed or implied in the
forward-looking statements. These risks, uncertainties and other factors include, among others: the
success of the profiled company's operations; the size and growth of the market for the company's
products and services; the company's ability to fund its capital requirements in the near term and
long term; pricing pressures; changes in business strategy, practices or customer relationships;
general worldwide economic and business conditions; currency exchange and interest rate
fluctuations; government, statutory, regulatory or administrative initiatives affecting the
company's business.
INDEMNIFICATION/RELEASE OF LIABILITY
By reading this communication, you acknowledge that you have read and understand this disclaimer in
full, and agree and accept that the Publisher provides no warranty in respect of the communication
or the profiled company and accepts no liability whatsoever. You acknowledge and accept this
disclaimer and that, to the greatest extent permitted under applicable law, you release and hold
harmless the Publisher from any and all liability, damages, injury and adverse consequences arising
from your use of this communication. You further agree that you are solely responsible for any
financial outcome related to or arising from your investment decisions.
TERMS OF USE AND DISCLAIMER
By reading this communication, you acknowledge that you have read and understand this disclaimer in
full, and agree and accept that the Publisher provides no warranty in respect of the communication
or the profiled company and accepts no liability whatsoever. You acknowledge and accept this
disclaimer and that, to the greatest extent permitted under applicable law, you release and hold
harmless the Publisher from any and all liability, damages, injury and adverse consequences arising
from your use of this communication. You further agree that you are solely responsible for any
financial outcome related to or arising from your investment decisions.
INTELLECTUAL PROPERTY
All trademarks used in this communication are the property of their respective trademark holders.
Other than WhatsOnFinance.com, the Publisher is not affiliated, connected, or associated with, and
the communication is not sponsored, approved, or originated by, the trademark holders unless
otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks
other than WhatsOnFinance.com.
AUTHORS PARTNER CONTENT
All of the content found on this page was authored by our 3rd party affiliate partner.
WhatsOnFinance, IRP Holdings Corporation dba IRPub, and our affiliates are not responsible for the
content or accuracy of this article.
DISCLOSURE OF HOLDINGS
WhatsOnFinance, IRP Holdings Corporation dba IRPub, DO NOT hold any position in the stock(s) and/or
financial instrument(s) mentioned in the above piece. We have been paid to produce this piece by the
Company or companies mentioned above. However, Anchor IR, a partner company to IRP Holdings, has
received a contract from the company containing an offer to purchase Stock Options at a strike price
of $2.56 CAD. The total amount of options that may be exercised/purchased is up to 150,000 Shares.
This Stock Option Agreement is NOT an award of shares to
AnchorIR LLC, it is an opportunity for Anchor IR to take a position in the company pursuant to the
Agreement. Should Anchor IR decide to execute their Options, this information will be updated and
disclosed immediately reflecting the amount of options executed and the date of execution.
